Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity

Alparslan Şahin,Z. Gürsel-Özkurt,Muhammed Sahin,Fatih Mehmet Türkcü,Adnan Yıldırım,Harun Yüksel

Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity

2018

Alparslan Şahin
Z. Gürsel-Özkurt
Muhammed Sahin
Fatih Mehmet Türkcü
Adnan Yıldırım
Harun Yüksel

Aim We aimed to investigate the effectivity of the 0.0625 mg dose of bevacizumab in patients with retinopathy of prematurity (ROP) and compare the results with 0.625 mg dose of intravitreal bevacizumab (IVB) injection.

Keywords:

Bevacizumab
Retinopathy of prematurity
Medicine
Surgery
Ophthalmology
in patient
ultra low dose
low dose
Diabetes mellitus
intravitreal bevacizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations